Environmental toxin interactions with genetic risks for Parkinson's disease
Environmental toxin interactions with genetic risks for Parkinson's disease
批准号:
7477104
负责人:
David Evan Krantz
金额:
$35.84万
依托单位国家:
美国
项目类别:
财政年份:
2007
资助国家:
美国
项目状态:
已结题
起止时间:
2007-08-01 至 2011-05-31
关键词:
AffectAgeAnimal ModelAttentionCessation of lifeContractsDataDiseaseDopamineDopaminergic CellDrosophila genusDrosophila melanogasterEnvironmentEnvironmental Risk FactorFutureGenesGeneticGenetic ModelsGenetic RiskHomeostasisHomologous GeneHumanLinkMitochondriaModelingMutationNerve DegenerationOnset of illnessOrganismParaquatParkinson DiseasePathway interactionsPesticidesPhenotypePlayProcessProteinsRelative (related person)RiskRisk FactorsRoleRotenoneSynaptic VesiclesTestingThinkingTimeToxic Environmental SubstancesToxic effectToxinUbiquitinationWorkdiphenyldisorder riskdopaminergic neuronenvironmental agentflygene environment interactioninterestkillingsmembermitochondrial dysfunctionmutantneurotoxicparkin gene/proteinresearch studysynergismubiquitin ligasevesicular monoamine transporter
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant):
Both genes and environmental toxins may act as risk factors for Parkinson's disease (PD), but their potential interplay remains poorly understood. This proposal seeks to investigate gene-environment interactions that are potentially relevant to PD using the model organism Drosophila melanogaster. Attention will be directed on genes and toxins associated with PD that affect mitochondrial dysfunction, protein ubiquitination and dopamine homeostasis. Over-expression of the Drosophila vesicular monoamine transporter (DVMAT) has been shown to protect against the neurotoxic effects of at least one mutant gene associated with PD (parkin), and at least one pesticide (rotenone) that selectively kills dopaminergic neurons. This study will therefore test the hypothesis that the neuroprotective effects of VMAT will extend to a different toxin, paraquat, thought to act by a different mechanism than rotenone, and whether this requires its localization to synaptic vesicles and if it is required at a specific time relative to neurotoxic insults. Studies here have shown that over-expression of mutant forms of parkin can cause dopaminergic cell degeneration in flies. If mutations in parkin function as a risk factor for PD, then additional environmental agents may enhance this risk. This study will test this hypothesis using rotenone, paraquat and other agents. Parallel experiments for gene-environment interactions will be performed with the PD related gene, pink1. Finally, already established pink mutant phenotypes will be used to screen for agents that rescue the neurotoxic effects of mitochondrial dysfunction.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Models of Neuromodulatory Circuits in Drosophila
-
批准号:10437744
-
项目类别:
-
资助金额:$41.07万
-
财政年份:2018
-
负责人:David Evan Krantz
-
依托单位:
Models of Neuromodulatory Circuits in Drosophila
-
批准号:10201438
-
项目类别:
-
资助金额:$41.07万
-
财政年份:2018
-
负责人:David Evan Krantz
-
依托单位:
Identification of the Kenyon Cell Neurotransmitter
-
批准号:9191360
-
项目类别:
-
资助金额:$19.25万
-
财政年份:2016
-
负责人:David Evan Krantz
-
依托单位:
The Influence of Neurotransmitter Transport on Aminergic Neuromodulation
-
批准号:9059776
-
项目类别:
-
资助金额:$38.5万
-
财政年份:2015
-
负责人:David Evan Krantz
-
依托单位:
Project 2: Pesticide Mechanisms and PD: Genetic Studies In Flies
-
批准号:8292135
-
项目类别:
-
资助金额:$31.67万
-
财政年份:2011
-
负责人:David Evan Krantz
-
依托单位:
Environmental toxin interactions with genetic risks for Parkinson's disease
-
批准号:7911174
-
项目类别:
-
资助金额:$30.65万
-
财政年份:2009
-
负责人:David Evan Krantz
-
依托单位:
Environmental toxin interactions with genetic risks for Parkinson's disease
-
批准号:7818366
-
项目类别:
-
资助金额:$19.23万
-
财政年份:2009
-
负责人:David Evan Krantz
-
依托单位:
Trafficking of the Drosophila Vesicular Monoamine Transporter
-
批准号:8068853
-
项目类别:
-
资助金额:$30.24万
-
财政年份:2007
-
负责人:David Evan Krantz
-
依托单位:
Trafficking of the Drosophila Vesicular Monoamine Transporter
-
批准号:7317390
-
项目类别:
-
资助金额:$31.89万
-
财政年份:2007
-
负责人:David Evan Krantz
-
依托单位:
Trafficking of the Drosophila Vesicular Monoamine Transporter
-
批准号:7808800
-
项目类别:
-
资助金额:$30.54万
-
财政年份:2007
-
负责人:David Evan Krantz
-
依托单位:
Environmental toxin interactions with genetic risks for Parkinson's disease
-
批准号:8232880
-
项目类别:
-
资助金额:$15.0万
-
财政年份:2007
-
负责人:David Evan Krantz
-
依托单位:
Environmental toxin interactions with genetic risks for Parkinson's disease
-
批准号:7289933
-
项目类别:
-
资助金额:$36.58万
-
财政年份:2007
-
负责人:David Evan Krantz
-
依托单位:
Environmental toxin interactions with genetic risks for Parkinson's disease
-
批准号:7624657
-
项目类别:
-
资助金额:$35.84万
-
财政年份:2007
-
负责人:David Evan Krantz
-
依托单位:
Trafficking of the Drosophila Vesicular Monoamine Transporter
-
批准号:7618462
-
项目类别:
-
资助金额:$30.54万
-
财政年份:2007
-
负责人:David Evan Krantz
-
依托单位:
Trafficking of the Drosophila Vesicular Monoamine Transporter
-
批准号:7477960
-
项目类别:
-
资助金额:$30.54万
-
财政年份:2007
-
负责人:David Evan Krantz
-
依托单位:
VESICULAR NEUROTRANSMITTER TRANSPORT IN DROSOPHILA
-
批准号:6440330
-
项目类别:
-
资助金额:$14.65万
-
财政年份:2001
-
负责人:David Evan Krantz
-
依托单位:
REGULATION OF VESICULAR NEUROTRANSMITTER TRANSPORT IN D*
-
批准号:6524656
-
项目类别:
-
资助金额:$15.25万
-
财政年份:2001
-
负责人:David Evan Krantz
-
依托单位:
REGULATION OF VESICULAR NEUROTRANSMITTER TRANSPORT
-
批准号:6185454
-
项目类别:
-
资助金额:$3.72万
-
财政年份:1999
-
负责人:David Evan Krantz
-
依托单位:
REGULATION OF VESICULAR NEUROTRANSMITTER TRANSPORT
-
批准号:6369401
-
项目类别:
-
资助金额:$3.56万
-
财政年份:1999
-
负责人:David Evan Krantz
-
依托单位:
REGULATION OF VESICULAR NEUROTRANSMITTER TRANSPORT
-
批准号:2859374
-
项目类别:
-
资助金额:$6.74万
-
财政年份:1999
-
负责人:David Evan Krantz
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: